昂利康：获得药品注册证书

Group 1 - The core point of the article is that Anglikon has received the drug registration certificate for Mesobam Injection from the National Medical Products Administration [2] Group 2 - The announcement was made on the evening of July 30 [2] - The registration certificate is a significant regulatory milestone for the company [2] - This development may enhance the company's product portfolio and market position [2]